Concepedia

Jeffrey L. Wolf

JL

Statistics

Publications

77

Citations

4.2K

H-Index

36

Active since

1973

Affiliations

University of California, San Francisco(Current)

UCSF Helen Diller Family Comprehensive Cancer Center

Dana-Farber Cancer Institute

Millennium Engineering and Integration (United States)

Icahn School of Medicine at Mount Sinai

Jeffrey L. Wolf is an author at University of California, San Francisco specializing in multiple myeloma therapy, multiple myeloma, and medicine.

ORCID

Publications per year

1973–2025

77

Publications

77

Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma

Shaji Kumar, Ian W. Flinn, Paul G. Richardson et al. · Blood · 2012 · 451 citations · Full text

, , +13

Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma

Sundar Jagannath, Brian G.M. Durie, Jeffrey L. Wolf et al. · British Journal of Haematology · 2005 · 399 citations · Full text

, , +13

Bone-Marrow Ablation and Allogeneic Marrow Transplantation in Acute Leukemia

Karl G. Blume, Ernest Beutler, K. Bross et al. · New England Journal of Medicine · 1980 · 265 citations

, , +16

High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails

Brian R. Shy, Vivasvan S. Vykunta, Alvin Ha et al. · Nature Biotechnology · 2022 · 222 citations · Full text

, , +14

A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma

Thomas G. Martin, Rachid Baz, Don M. Benson et al. · Blood · 2017 · 166 citations · Full text

, , +13

1–5 of 77